Maternal pregnancy estradiol (E2) concentrations have been associated with risk in young women who subsequently developed breast cancer.4–7 The direction of the associations with E2 appears to depend on age at breast cancer diagnosis, with an elevated risk at younger ages and a reduced risk at older ages8 and may be limited to hormone receptor negative (HR-) breast cancer cases.5 Here, NR4A1 is linked to breast cancer.